Global Vectra (GLOBALVECT)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

When I look at Global Vectra, I see a business that fails the tests Graham and I would apply. Airlines are tough, capital-hungry, commodity-like businesses, and this one shows all the scars. The latest quarter had sales of ₹147 Cr but a net loss of ₹11 Cr. Return on equity is deeply negative at -116.17%, meaning shareholder capital is being destroyed, not compounded. Book value is just ₹8.48 per share, yet the stock trades at ₹189, a P/B of 22.29. That is an extraordinarily rich price for a company with a shrunken equity base. Debt to equity at 140.97 is alarming; leverage is doing the opposite of what leverage should do. There is a positive ROCE of 6.66%, which suggests operations can earn something before interest costs, but those debt costs overwhelm the profit line. Sales growth is only 3.05% while profit growth is -270.33%; that is no pricing power. Piotroski score of 4/9 reinforces a weak financial position. Dividend yield is zero, so there is no return to patient owners. Promoter holding of 75% at least shows alignment, but it does not offset the balance sheet risk. At ₹189, with no meaningful P/E and negative net profit, I see no margin of safety. This is a cyclical business in a difficult phase. I would prefer to wait until earnings turn positive and debt is reduced before even considering it. Price is what you pay; value is what you get. Here the value is not visible to me.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer